The target audience is pharmacists who care for patients with myelofibrosis and other stakeholders in hematology/oncology practice
The goal of this activity is to improve the knowledge, confidence, and competence of learners in the management of patients with myelofibrosis.
Upon completion of this activity, participants should be able to:
Interpret clinical efficacy and safety data to develop individualized treatment plans for patients with myelofibrosis
Recommend evidence-based treatment plan for suboptimal response or loss of response to first-line therapy
Devise prevention, mitigation, and management strategies for medication-related adverse events for second-line and novel therapies for myelofibrosis
Communicate with caregivers and patients regarding their disease, symptoms, and treatment options
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Justin Arnall, PharmD, BCOP
Clinical Coordinator, Hematology
Specialty Pharmacy Service, Atrium Health
Charlotte, North Carolina
Assistant Professor of Clinical Education
Division of Practice Advancement and Clinical Education
UNC Eshelman School of Pharmacy
Chapel Hill, North Carolina
Justin Arnall, PharmD, BCOP: consultant/advisor/speaker: CTI, HEMA, Novo Nordisk.
Victoria R. Nachar, PharmD, BCOP
Clinical Pharmacist Specialist
University of Michigan
Rogel Cancer Center
Ann Arbor, Michigan
Victoria Nachar, PharmD, BCOP, has no relevant financial relationships to disclose.
The planners and content peer reviewers from ProCE, LLC and Clinical Care Options, LLC do not have any relevant financial relationships to disclose.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This activity is jointly provided by ProCE, LLC and Clinical Care Options, LLC. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-23-015-H01-P has been assigned to this home study application-based activity. This activity is approved for 1 contact hour (0.10 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65 % or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.